Publication | Closed Access

Metforminium Decavanadate (MetfDeca) Treatment Ameliorates Hippocampal Neurodegeneration and Recognition Memory in a Metabolic Syndrome Model

Neurodegenerative DiseasesAlzheimer's DiseaseBrain FunctionMetabolic Syndrome ModelMedicineDementiaMemory LossMemoryNeuropharmacologyMetforminium DecavanadateRecognition MemoryNeurochemical BiomarkersNeuroscienceNeurologyNeurodegenerationPharmacologyNeurochemistrySocial Sciences